CCIA
BVS icon

Campbell & Co Investment Adviser’s Bioventus BVS Stock Holding History

Campbell & Co Investment Adviser’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$533K Sell
56,415
-3,875
-6% -$37K 0.03% 752
2026
Q1 		$550K Buy
60,290
+45,985
+321% +$386K 0.03% 712
2025
Q4 		$106K Sell
14,305
-12,727
-47% -$91.5K 0.01% 1088
2025
Q3 		$181K Sell
27,032
-40,778
-60% -$283K 0.01% 1015
2025
Q2 		$449K Buy
+67,810
New +$481K 0.03% 822

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.42B AUM 22.12% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Campbell & Co Investment Adviser's BVS Position: Q2 2026 in Review

Campbell & Co Investment Adviser reduced its Bioventus (BVS) stake by 6.4% in Q2 2026, selling an estimated $37K and leaving 56,415 shares worth $533K. The position accounts for 0.03% of the portfolio, ranked #752.

Campbell & Co Investment Adviser first reported a position in BVS in Q2 2025 and has held it in 5 quarters since. The position peaked at $550K in Q1 2026. 37 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Campbell & Co Investment Adviser held 56,415 shares of Bioventus worth $533K as of Q2 2026.
  • Campbell & Co Investment Adviser sold 3,875 Bioventus shares in Q2 2026, an estimated $37K.
  • Bioventus made up 0.03% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #752 holding.
  • Campbell & Co Investment Adviser first reported a position in Bioventus in Q2 2025 and has held it in 5 quarters since.
  • Campbell & Co Investment Adviser's Bioventus position peaked at $550K in Q1 2026.
  • 37 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.